Analysts' Top Healthcare Picks: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Armata Pharmaceuticals (ARMP)
Structure Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (PTCT), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and UnitedHealth (UNH)
Structure Therapeutics Analyst Ratings
Structure Therapeutics Analyst Ratings
Structure Therapeutics (NASDAQ:GPCR): Analysts Say This GLP-1 Stock Can Rise 130%
Buy Rating on Structure Therapeutics' GSBR-1290 for Non-T2D Obesity Potential
Structure Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), 4D Molecular Therapeutics (FDMT) and Sanofi (OtherSNYNF)
Structure Therapeutics Analyst Ratings
Buy Rating for Structure Therapeutics: Promising Pipeline and Financial Stability Ahead of Key Clinical Data Release
Structure Therapeutics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Corcept Therapeutics (CORT), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
Structure Therapeutics Analyst Ratings
Buy Rating Affirmed for Structure Therapeutics on Upcoming GSBR-1290 Phase 2a Data Optimism
Buy Rating for Structure Therapeutics on Strong Obesity Drug Prospects and Strategic Partnerships
Structure Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)
Analysts Are Bullish on These Healthcare Stocks: Immuneering (IMRX), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and Aligos Therapeutics (ALGS)